Cargando…
Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
The anti-diabetic and oral hypoglycaemic agent metformin, first used clinically in 1958, is today the first choice or ‘gold standard’ drug for the treatment of type 2 diabetes and polycystic ovary disease. Of particular importance for the treatment of diabetes, metformin affords protection against d...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5588255/ https://www.ncbi.nlm.nih.gov/pubmed/26021280 http://dx.doi.org/10.1159/000381643 |